Radiation Therapy vs. Observation Following Gemcitabine and Cisplatin for Inoperable Localized Liver Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
34 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Research Institute of the Mcgill University Health Centre (muhc)
Montreal, Quebec, Canada
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Sutter Medical Center Sacramento
Sacramento, California, United States
- Emory University Hospital Midtown
Atlanta, Georgia, United States
- Emory University Hospital/winship Cancer Institute
Atlanta, Georgia, United States
- Piedmont Hospital
Atlanta, Georgia, United States
- Queen'S Medical Center
Honolulu, Hawaii, United States
- Northwestern University
Chicago, Illinois, United States
- Decatur Memorial Hospital
Decatur, Illinois, United States
- Loyola University Medical Center
Maywood, Illinois, United States
- Osf Saint Francis Medical Center
Peoria, Illinois, United States
- Northwestern Medicine Cancer Center Warrenville
Warrenville, Illinois, United States
- Indiana University/melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
- Maryland Proton Treatment Center
Baltimore, Maryland, United States
- Boston Medical Center
Boston, Massachusetts, United States
- Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
- Lahey Hospital and Medical Center
Burlington, Massachusetts, United States
- Missouri Baptist Medical Center
St Louis, Missouri, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Dartmouth Hitchcock Medical Center/dartmouth Cancer Center
Lebanon, New Hampshire, United States
- University of New Mexico Cancer Center
Albuquerque, New Mexico, United States
- Mount Sinai Hospital
New York, New York, United States
- University of Rochester
Rochester, New York, United States
- University of Cincinnati Cancer Center-Uc Medical Center
Cincinnati, Ohio, United States
- Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
- Legacy Good Samaritan Hospital and Medical Center
Portland, Oregon, United States
- M D Anderson Cancer Center
Houston, Texas, United States
- Huntsman Cancer Institute/university of Utah
Salt Lake City, Utah, United States
- University of Vermont Medical Center
Burlington, Vermont, United States
- Fhcc Proton Therapy Center
Seattle, Washington, United States
- University of Washington Medical Center - Montlake
Seattle, Washington, United States
- West Virginia University Healthcare
Morgantown, West Virginia, United States
- University of Wisconsin Carbone Cancer Center - University Hospital
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Sept 2014
- Primary completion
- 2 Jul 2018
- Completion
- 2 Jul 2018
- Last update posted
- 19 May 2026
- Registered enrollment
- 1
- Registry id
- NCT02200042
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.